Understanding the Role of Flavonoid Based Small Molecules in Modulating the Oncogenic Protein-Protein Interactions: A Quest for Therapeutic Arsenal
- 1 January 2022
- journal article
- research article
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1248, 131511
Abstract
No abstract availableKeywords
Funding Information
- University Grants Committee
- Anusandhan National Research Foundation (ECR/2017/001028)
This publication has 42 references indexed in Scilit:
- An empirical framework for binary interactome mappingNature Methods, 2008
- Estimating the size of the human interactomeProceedings of the National Academy of Sciences, 2008
- Increased p21 expression and complex formation with cyclin E/CDK2 in retinoid‐induced pre‐B lymphoma cell apoptosisFEBS Letters, 2006
- The p53 pathway: positive and negative feedback loopsOncogene, 2005
- Flavonoids: antioxidants or signalling molecules?Free Radical Biology and Medicine, 2004
- In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2Science, 2004
- Inhibiting the p53–MDM2 interaction: an important target for cancer therapyNature Reviews Cancer, 2003
- Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation DomainScience, 1996
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- Structure-activity relationships for hallucinogenic N,N-dialkyltryptamines: photoelectron spectra and serotonin receptor affinities of methylthio and methylenedioxy derivativesJournal of Medicinal Chemistry, 1982